Cerebrovascular accidents.

2019 ◽  
pp. 371-398
Author(s):  
Michelle M. Haddad ◽  
Gitendra Uswatte ◽  
Victor W. Mark ◽  
Kathleen T. Bechtold
Keyword(s):  
Cerebrovascular Accidents

Diagnosis and treatment of disorders of urination after cerebrovascular accidents

2015 ◽  
Vol 17 (9) ◽  
pp. 59-62
Author(s):  
G.G. Krivoborodov ◽  
◽  
N.S. Efremov ◽  
E.I. Tur ◽  
◽  
...  
Keyword(s):  
Diagnosis And Treatment ◽  
Cerebrovascular Accidents

Role of computed tomography in evaluation of cerebrovascular accidents

2018 ◽  
Vol 6 (2) ◽  
pp. 34-37
Author(s):  
Venkateshwaran A ◽  
◽  
Akash Lata ◽  
N Parthipan ◽  
◽  
...  
Keyword(s):  
Computed Tomography ◽  
Cerebrovascular Accidents

scholarly journals Evaluation of risk factors for cerebral palsy

2021 ◽  
Vol 57 (1) ◽  
Author(s):  
Dina Salama Abd Elmagid ◽  
Hend Magdy
Keyword(s):  
Risk Factors ◽  
Cerebral Palsy ◽  
Intracranial Hemorrhage ◽  
Cns Infection ◽  
Motor Impairments ◽  
Cerebrovascular Accidents ◽  
Common Causes ◽  
Children With Cerebral Palsy ◽  
Infant Brain ◽  
Cns Malformation

Abstract Background Cerebral palsy (CP) has been identified as one of the most important and common causes of childhood disabilities worldwide and is often accompanied by multiple comorbidities. CP is defined as a group of disorders of the development of movement and posture, causing activity limitation that are attributed to non-progressive disturbances that occurred in the developing fetal or infant brain. The objective of our study was to describe main clinical pattern and motor impairments of our patients, and to evaluate the presence of risk factors and if there is a relation to the type of cerebral palsy. Methods Children with cerebral palsy were retrospectively enrolled over 2 years from the neurology outpatient clinics. Cerebral palsy risk factors and motor impairments were determined through caregiver interviews, review of medical records, and direct physical examination. Results One thousand children with cerebral palsy were enrolled. Subjects were 64.4% male, with a median age of 2.5 years. The risk factors for cerebral palsy in our study were antenatal (21%), natal and post-natal (30.5%), post-neonatal (17.1%), and unidentified (31.4%). Antenatal as CNS malformation (26.6%), maternal DM (17.6%), prolonged rupture of membrane (11.9%), maternal hemorrhage (10.4%), and pre-eclampsia (4.7%). Natal and post-natal as hypoxic ischemic encephalopathy (28.5%), infection (16.3%), hyperbilirubinemia (12.7%), cerebrovascular accidents (8.8%), meconium aspiration (6.2%), and intracranial hemorrhage. Post-neonatal as CNS infection (34.5%), cerebrovascular accidents (28.6%), sepsis (23.9%), and intracranial hemorrhage (8.7%). Conclusions Cerebral palsy has different etiologies and risk factors. Further studies are necessary to determine optimal preventative strategies in these patients.

scholarly journals Subarachnoid haemorrhage in pregnancy after in vitro fertilisation with egg donation: a case report and review of the literature

2021 ◽  
Vol 15 ◽  
pp. 263349412110235
Author(s):  
Noemi J. Hughes ◽  
Saeed M.S.R. Choudhury ◽  
Sidath H. Liyanage ◽  
Munawar Hussain
Keyword(s):  
Subarachnoid Haemorrhage ◽  
Rare Case ◽  
Egg Donation ◽  
In Vitro Fertilisation ◽  
Arterial Aneurysm ◽  
Matrix Metalloprotease ◽  
Review Of The Literature ◽  
Cerebrovascular Accidents ◽  
Increase Risk

We report a rare case of in vitro fertilisation (IVF) with egg donation complicated by a subarachnoid haemorrhage (SAH). Haemostatic changes related to IVF are known to increase risk of venous thrombosis; however, less is known regarding the risk of arterial events such as cerebrovascular accidents (CVA). Matrix metalloprotease-9 (MMP-9) upregulated in IVF patients may have a role in arterial aneurysm formation, which is the most common cause of SAH. Further research is required to assess the benefit of screening for risk of CVA and the best way to manage this in the IVF population. This may have implications for the ethics of offering certain procedures such as egg donation to women with pre-existing risk factors.

scholarly journals Exoskeletons, Rehabilitation and Bodily Capacities

2021 ◽  
pp. 1357034X2110256
Author(s):  
Denisa Butnaru
Keyword(s):  
Spinal Cord ◽  
Spinal Cord Injury ◽  
Crucial Role ◽  
Spinal Cord Injuries ◽  
Main Task ◽  
Cerebrovascular Accidents ◽  
Complex Processes ◽  
Cord Injury ◽  
Neurological Conditions

Motility impairments resulting from spinal cord injuries and cerebrovascular accidents are increasingly prevalent in society, leading to the growing development of rehabilitative robotic technologies, among them exoskeletons. This article outlines how bodies with neurological conditions such as spinal cord injury and stroke engage in processes of re-appropriation while using exoskeletons and some of the challenges they face. The main task of exoskeletons in rehabilitative environments is either to rehabilitate or ameliorate anatomic functions of impaired bodies. In these complex processes, they also play a crucial role in recasting specific corporeal phenomenologies. For the accomplishment of these forms of corporeal re-appropriation, the role of experts is crucial. This article explores how categories such as bodily resistance, techno-inter-corporeal co-production of bodies and machines, as well as body work mark the landscape of these contemporary forms of impaired corporeality. While defending corporeal extension rather than incorporation, I argue against the figure of the ‘cyborg’ and posit the idea of ‘residual subjectivity’.

scholarly journals Cerebrovascular Accidents Associated with Sorafenib in Hepatocellular Carcinoma

2011 ◽  
Vol 2011 ◽  
pp. 1-3 ◽  
Author(s):  
Muhammad W. Saif ◽  
Iris Isufi ◽  
Jennifer Peccerillo ◽  
Kostas N. Syrigos
Keyword(s):  
Hepatocellular Carcinoma ◽  
Cerebrovascular Accident ◽  
Systolic Function ◽  
Laboratory Data ◽  
Multikinase Inhibitor ◽  
Significant Stenosis ◽  
Cerebrovascular Accidents ◽  
Normal Systolic Function ◽  
Cerebrovascular Events ◽  
Gender And Age

Sorafenib is an oral angiogenetic multikinase inhibitor approved in the treatment of renal and hepatocellular carcinoma. Bleeding and venous thrombotic events have been described with angiogenetic agents but cerebrovascular accidents are rarely reported. We report two cases of patients with hepatocellular carcinoma who developed a cerebrovascular accident while on sorafenib. Neither patient had any risk factors for the cerebrovascular events apart from gender and age in the second patient. Laboratory data were noncontributory. The head CT scan did not reveal acute abnormalities. No hemodynamically significant stenosis was visible in the carotid ultrasound, and the echocardiogram showed normal size of the heart chambers and normal systolic function of the left ventricle. Sorafenib was discontinued in both cases. Physicians should monitor patients receiving sorafenib for neurologic symptoms, and in the absence of other etiology, prompt discontinuation of this drug should be considered.

scholarly journals SMAD3 rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients

PLoS ONE ◽  
2013 ◽  
Vol 8 (10) ◽  
pp. e77695 ◽  
Author(s):  
Mercedes García-Bermúdez ◽  
Raquel López-Mejías ◽  
Fernanda Genre ◽  
Santos Castañeda ◽  
Carlos González-Juanatey ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Gene Polymorphism ◽  
Subclinical Atherosclerosis ◽  
Cerebrovascular Accidents ◽  
Reduced Risk
Sign in / Sign up

Export Citation Format

Share Document